Skip to main content
Top
Published in: Journal of General Internal Medicine 12/2013

01-12-2013 | Clinical Image

Diltiazem-Associated Hyperpigmentation

Authors: Michelle Campbell, MD, Jesleen Ahluwalia, MD, Alice C. Watson, MD

Published in: Journal of General Internal Medicine | Issue 12/2013

Login to get access

Excerpt

A 59-year-old African American female presented with a one-year history of progressive skin darkening. Her only symptom was mild itching. Medications included diltiazem 180 mg daily (extended release), prescribed three years earlier. Examination revealed blue-gray reticular hyperpigmentation in a photodistributed pattern on the face, neck, “V of the chest,” and extensor forearms (Fig. 1a, b). Punch biopsy showed a predominantly lichenoid reaction with upper dermal melanophages.
Literature
1.
go back to reference Jaka A, Lopez-Pestana A, Tuneu A, Lobo C, Lopez-Nunez M, Ormaechea N. Letter: photodistributed reticulated hyperpigmentation related to diltiazem. Dermatol Online J. 2011;17(7):14.PubMed Jaka A, Lopez-Pestana A, Tuneu A, Lobo C, Lopez-Nunez M, Ormaechea N. Letter: photodistributed reticulated hyperpigmentation related to diltiazem. Dermatol Online J. 2011;17(7):14.PubMed
2.
go back to reference Kubo Y, Fukumoto D, Ishigami T, Hida Y, Arase S. Diltiazem-associated photodistributed hyperpigmentation: report of two Japanese cases and published work review. J Dermatol. 2010;37:807–11.PubMedCrossRef Kubo Y, Fukumoto D, Ishigami T, Hida Y, Arase S. Diltiazem-associated photodistributed hyperpigmentation: report of two Japanese cases and published work review. J Dermatol. 2010;37:807–11.PubMedCrossRef
3.
go back to reference Desai N, Alexis A, DeLeo V. Facial hyperpigmentation caused by diltiazem hydrochloride. Cutis. 2010;86(2):82–4.PubMed Desai N, Alexis A, DeLeo V. Facial hyperpigmentation caused by diltiazem hydrochloride. Cutis. 2010;86(2):82–4.PubMed
Metadata
Title
Diltiazem-Associated Hyperpigmentation
Authors
Michelle Campbell, MD
Jesleen Ahluwalia, MD
Alice C. Watson, MD
Publication date
01-12-2013
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 12/2013
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2530-1

Other articles of this Issue 12/2013

Journal of General Internal Medicine 12/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.